Stock Analysis·← Pickers

YI

111, Inc.

111, Inc. (YI) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 40.6, with 0/3 trend checks passing.

Price
$3.87
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
40.6
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

YI with MA50 and MA200

8.386.935.474.022.5607/3110/2401/2204/1707/15
YI2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$4.88-20.62% vs price
MA200
$5.24-26.15% vs price
RSI (14)
40.6Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for YI

111, Inc. (YI) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $3.87, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 20.6% and below the 200-day moving average by 26.1%.

Momentum and stretch context

YI currently has an RSI reading of 40.6, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing YI next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About 111, Inc.

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.

Sector
Healthcare
Industry
Medical - Distribution
CEO
Junling Liu
Employees
1,063
Market cap
$33.8M
Beta
0.63
52-week range
$2.48 – $11.17
Dividend
No
Exchange
NASDAQ
Country
CN
IPO date
12 Sept 2018
ISIN
US68247Q2012
CUSIP
68247Q201
Website
111.com.cn
Company profile data from Financial Modeling Prep. YI listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about YI

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.